The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
APHINITY trial (BIG 4-11): A randomized comparison of chemotherapy (C) plus trastuzumab (T) plus placebo (Pla) versus chemotherapy plus trastuzumab (T) plus pertuzumab (P) as adjuvant therapy in patients (pts) with HER2-positive early breast cancer (EBC).
 
Gunter Von Minckwitz
No Relationships to Disclose
 
Marion Jennifer Procter
No Relationships to Disclose
 
Evandro De Azambuja
No Relationships to Disclose
 
Dimitrios Zardavas
No Relationships to Disclose
 
Adam Knott
No Relationships to Disclose
 
Giuseppe Viale
No Relationships to Disclose
 
Thomas M. Suter
No Relationships to Disclose
 
Amal Arahmani
No Relationships to Disclose
 
Nathalie Rouchet
No Relationships to Disclose
 
Emma Clark
No Relationships to Disclose
 
Mark Benyunes
No Relationships to Disclose
 
Istvan Lang
No Relationships to Disclose
 
Christelle Levy
No Relationships to Disclose
 
Denise A. Yardley
No Relationships to Disclose
 
Jose Bines
No Relationships to Disclose
 
Richard D. Gelber
No Relationships to Disclose
 
Martine J. Piccart-Gebhart
No Relationships to Disclose
 
Jose Baselga
No Relationships to Disclose